Work

Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study

Year: 2014

Type: article

Study design: Clinical Trial

Source: Journal of Neuro-Oncology

DOI: 10.1007/s11060-014-1665-1

Authors: Roger J. Packer, Brian R. Rood, David C. Turner, Clinton F. Stewart, Michael Fisher, Christopher Smith, Tina Young-Pouissant, Stewart Goldman, Rishi Lulla, Anu Banerjee, Ian Pollack, Larry Kun, Arzu Onar-Thomas, Shengjie Wu, James M. Boyett, Maryam Fouladi

Institutions: Children's National, St. Jude Children's Research Hospital, Children's Hospital of Philadelphia, University of Pennsylvania, Boston Children's Hospital, Harvard University, Lurie Children's Hospital, University of California, San Francisco, University of Pittsburgh, Children's Hospital of Pittsburgh, Cincinnati Children's Hospital Medical Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors., G2709301131, G5051599379, Cancer Center Support Grant (CCSG)

OpenAlex ID: W2014063489

FWCI: 0.751

Cites: 17

Cited by: 23

Related to: 10